Using the MCF-7/Survivin cell line created with the CRISPR/Cas9 genome editing technology, we proved that Survivin might mediate tumor cell’s MDR via the PI3K/Akt/mTOR pathway. The gene discussed is AKT1; the disease is neoplasm.